Výsledky vyhľadávania - "Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use"
-
1
Autori: a ďalší
Zdroj: Kulasingam, A, Laustsen, S, Busk, M, Sand, N-P R, Winther, S, Kragholm, K, Hammid, O, Pedersen, K B, Vedsted, P, Kanstrup, H, Mortensen, M B, Grove, E L, Jensen, J M & Nørgaard, B L 2025, 'Rationale and design of VICAD-RISK study : Visualization of coronary artery disease for modification of risk factors', American Heart Journal, vol. 287, pp. 16-23. https://doi.org/10.1016/j.ahj.2025.04.002
Kulasingam, A, Laustsen, S, Busk, M, Sand, N-P R, Winther, S, Kragholm, K, Hammid, O, Pedersen, K B, Vedsted, P, Kanstrup, H, Mortensen, M B, Grove, E L, Jensen, J M & Nørgaard, B L 2025, 'Rationale and Design of VICAD-RISK study : Visualization of Coronary Artery Disease for Modification of Risk Factors', American Heart Journal, vol. 287, pp. 16-23. https://doi.org/10.1016/j.ahj.2025.04.002Predmety: Male, Coronary Angiography/methods, Computed Tomography Angiography/methods, Cholesterol, LDL/blood, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Risk Factors, Humans, Female, Middle Aged, Denmark/epidemiology, Coronary Artery Disease/diagnostic imaging, Randomized Controlled Trials as Topic
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40187715
https://vbn.aau.dk/da/publications/0fada2d3-e58b-4f85-b63b-473f0768b155
https://doi.org/10.1016/j.ahj.2025.04.002
http://www.scopus.com/inward/record.url?scp=105003422280&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/792739124/Rationale_and_design_of_VICAD-RISK_study_Visualization_of_coronary_artery_disease_for_modification_of_risk_factors_2025_.pdf
https://pure.au.dk/portal/en/publications/1ccf07d8-b648-4760-b4c6-c464a5144bbe
https://doi.org/10.1016/j.ahj.2025.04.002
http://www.scopus.com/inward/record.url?scp=105003422280&partnerID=8YFLogxK -
2
Autori: a ďalší
Zdroj: Gibson, C M, Duffy, D, Bahit, M C, Chi, G, White, H, Korjian, S, Alexander, J H, Lincoff, A M, Heise, M, Kingwell, B A, Nicolau, J C, Lopes, R D, Cornel, J H, Lewis, B S, Vinereanu, D, Goodman, S G, Bode, C, Steg, P G, Libby, P, Sacks, F M, Bainey, K R, Ridker, P M, Mahaffey, K W, Aylward, P, Nicholls, S J, Pocock, S J, Mehran, R, Harrington, R A, AEGIS-II Committees and Investigators & Jensen, S E 2024, 'Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels : the AEGIS-II trial', European Heart Journal, vol. 45, no. 47, pp. 5023-5038. https://doi.org/10.1093/eurheartj/ehae614
European Heart Journal, 45, 47, pp. 5023-5038
AEGIS-II Committees and Investigators 2024, 'Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels : the AEGIS-II trial', European Heart Journal, vol. 45, no. 47, pp. 5023-5038. https://doi.org/10.1093/eurheartj/ehae614Predmety: Male, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Apolipoprotein A-I, Secondary prevention, Apolipoprotein A-I/blood, Myocardial Infarction/drug therapy, Myocardial Infarction, Cholesterol, LDL, Middle Aged, Myocardial infarction, Treatment Outcome, Cholesterol, LDL/blood, Double-Blind Method, Humans, Female, Cholesterol efflux, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Infusions, Intravenous, Lipoproteins, HDL, Cardiology - Radboud University Medical Center, CSL112, Aged
-
3
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: European Journal of Preventive Cardiology, 2024, 31(15), 1792-1803
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
European journal of preventive cardiology, vol. 31, no. 15, pp. 1792-1803
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGYPredmety: Male, Dyslipidaemia, Time Factors, Epidemiology, LIPID-LOWERING THERAPY, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Medicine and Health Sciences, Humans, Prospective Studies, CARDIOVASCULAR EVENTS, Dyslipidemias, Aged, Hypolipidemic Agents, RISK, Cholesterol, LDL, Lipid, Middle Aged, Cardiovascular risk, PREVENTION, General medicine, internal medicine and other clinical medicine, Europe, Cholesterol, LDL/blood, Female, Dyslipidemias/drug therapy, Dyslipidemias/blood, Dyslipidemias/epidemiology, Dyslipidemias/diagnosis, Drug Therapy, Combination, Follow-Up Studies, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Biomarkers/blood, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Practice Guidelines as Topic, Heart Disease Risk Factors, Hypolipidemic Agents/therapeutic use, Guideline Adherence, Anticholesteremic Agents/therapeutic use, Real-world clinical trials, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiology and Cardiovascular Medicine, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38861400
https://hdl.handle.net/10902/36252
https://dspace.library.uu.nl/handle/1874/459023
http://hdl.handle.net/10138/588157
https://serval.unil.ch/notice/serval:BIB_2DE5249F1EBE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_2DE5249F1EBE6
https://serval.unil.ch/resource/serval:BIB_2DE5249F1EBE.P001/REF.pdf
https://hdl.handle.net/11570/3326492
https://doi.org/10.1093/eurjpc/zwae199
http://hdl.handle.net/1854/LU-01J9RYNBXTPND3JNRKGXZ8NFRV
http://doi.org/10.1093/eurjpc/zwae199
https://biblio.ugent.be/publication/01J9RYNBXTPND3JNRKGXZ8NFRV
https://biblio.ugent.be/publication/01J9RYNBXTPND3JNRKGXZ8NFRV/file/01JASSFEPSGMDJAXCK493VVDQM -
4
Autori: a ďalší
Zdroj: Eur Heart J Cardiovasc Pharmacother
Predmety: Male, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Denmark, Clinical Decision-Making, Practice Patterns, Drug Prescriptions, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Dyslipidemias/blood, Humans, Registries, Practice Patterns, Physicians', Retrospective Studies, Aged, Dyslipidemias, Primary prevention, Physicians', Statins, Cholesterol, LDL, Middle Aged, Cardiovascular disease, Denmark/epidemiology, LDL/blood, Primary Prevention, Cholesterol, Treatment Outcome, Cardiovascular Diseases, Original Article, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases/prevention & control, Biomarkers/blood, Biomarkers
-
5
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Kiss, P A J, Uijl, A, de Boer, A R, Duk, T C X, Grobbee, D E, Hollander, M, Smits, E, Sturkenboom, M C J M & Peters, S A E 2024, 'Sex differences in the intensity of statin prescriptions at initiation in a primary care setting', Heart, vol. 110, no. 15, heartjnl-2023-323722, pp. 981-987. https://doi.org/10.1136/heartjnl-2023-323722
Predmety: Male, Adult, Drug Prescriptions/statistics & numerical data, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Practice Patterns, Drug Prescriptions, Physicians'/statistics & numerical data, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, 80 and over, Journal Article, Humans, Electronic Health Records, Practice Patterns, Physicians', 10. No inequality, Aged, Aged, 80 and over, Primary Health Care, Cholesterol, LDL, Middle Aged, LDL/blood, 3. Good health, Cholesterol, Cardiovascular Diseases, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiology and Cardiovascular Medicine, Cardiovascular Diseases/prevention & control
Popis súboru: application/pdf
-
6
Autori: a ďalší
Zdroj: European Journal of Vascular and Endovascular Surgery. 67:570-582
Predmety: Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Rupture, Dietary Supplements, Disease Progression, Humans, Abdominal/diagnostic imaging, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Metformin, 3. Good health, Aortic Aneurysm, Aortic Aneurysm, Abdominal
-
7
Autori: a ďalší
Zdroj: Nat Commun
Nature Communications, Vol 16, Iss 1, Pp 1-18 (2025)
Nature communications, vol. 16, no. 1, pp. 2913Predmety: Male, Glycated Hemoglobin, Science, Middle Aged, Polymorphism, Single Nucleotide, Article, Metformin, United Kingdom, Humans, Electronic Health Records, Biological Specimen Banks, Genome-Wide Association Study, Pharmacogenetics/methods, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Cardiovascular Diseases/genetics, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/metabolism, Metformin/therapeutic use, Metformin/pharmacology, Aged, Glycated Hemoglobin/metabolism, Antihypertensive Agents/therapeutic use, Liver-Specific Organic Anion Transporter 1/genetics, Liver-Specific Organic Anion Transporter 1/metabolism, Pharmacogenetics, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Antihypertensive Agents
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40133288
https://doaj.org/article/578d7278676e4e239b8319624349326f
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D5905DCFB92E7
https://serval.unil.ch/notice/serval:BIB_D5905DCFB92E
https://serval.unil.ch/resource/serval:BIB_D5905DCFB92E.P001/REF.pdf -
8
Autori: a ďalší
Zdroj: Hepatol Commun
Fuller, H, Tittanegro, T H, Maini, A A, China, L, Rhodes, F, Becares Salles, N, Mukhopadhyay, S, Moore, B & O'Brien, A 2025, ' Hyperbilirubinemia at hospitalization predicts nosocomial infection in decompensated cirrhosis : Data from ATTIRE trial ', Hepatology Communications, vol. 9, no. 4, e0648 . https://doi.org/10.1097/HC9.0000000000000648Predmety: Male, Liver Cirrhosis, Cross Infection, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Bilirubin, Liver Cirrhosis/blood, Middle Aged, Bilirubin/blood, Hospitalization, Hyperbilirubinemia/blood, Cross Infection/blood, Bacterial Translocation, Humans, Original Article, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Biomarkers/blood, Biomarkers, Aged, Hyperbilirubinemia
Popis súboru: application/pdf
-
9
Autori: a ďalší
Zdroj: Hansen, M K, Mortensen, M B, Olesen, K K W, Thrane, P G, Thomsen, R W & Maeng, M 2024, 'Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes : The Western Denmark Heart Registry', European Journal of Preventive Cardiology, vol. 31, no. 10, pp. 1238–1248. https://doi.org/10.1093/eurjpc/zwae119
Predmety: Male, Time Factors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Denmark, Risk Assessment, Risk Factors, Diabetes Mellitus/blood, Dyslipidemias/blood, Diabetes Mellitus, Secondary Prevention, Humans, Registries, Aged, Dyslipidemias, Secondary prevention, Diabetes, Statin, Middle Aged, Cardiovascular disease, Denmark/epidemiology, 3. Good health, Cholesterol, Heart Disease Risk Factors, Residual cardiovascular risk, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Biomarkers/blood, Biomarkers
-
10
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Adv Ther
Predmety: ddc:610, Anticholesteremic Agents, Cholesterol, LDL, Antibodies, Monoclonal, Humanized, Cardiovascular Diseases/drug therapy [MeSH], LDL-C, Humans [MeSH], Treatment Outcome [MeSH], Guidelines, Retrospective Studies [MeSH], Cardiovascular risk, Risk Factors [MeSH], Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use [MeSH], Evolocumab, Heart Disease Risk Factors [MeSH], Cholesterol, LDL [MeSH], Antibodies, Monoclonal, Humanized/therapeutic use [MeSH], Original Research, PCSK9 inhibitors, Registry, Anticholesteremic Agents/therapeutic use [MeSH], 3. Good health, Treatment Outcome, Cardiovascular Diseases, Heart Disease Risk Factors, Risk Factors, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Retrospective Studies
Popis súboru: application/pdf
-
11
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Int J Stroke
International journal of stroke, vol. 18, no. 10, pp. 1219-1227
Moutzouri, Elisavet; Glutz, Matthias; Abolhassani, Nazanin; Feller, Martin; Adam, Luise; Gencer, Baris; Del Giovane, Cinzia; Bétrisey, Sylvain; Paladini, Rebecca E; Hennings, Elisa; Aeschbacher, Stefanie; Beer, Jürg H; Moschovitis, Giorgio; Seiffge, David J; De Marchis, Gian Marco; Coslovsky, Michael; Reichlin, Tobias; Conte, Giulio; Sinnecker, Tim; Schwenkglenks, Matthias; ... (2023). Association of Statin Use and Lipid Levels with Cerebral Microbleeds and Intracranial Hemorrhage in Patients with Atrial Fibrillation: a Prospective Cohort Study. International journal of stroke, 18(10), pp. 1219-1227. SAGE 10.1177/17474930231181010 <http://dx.doi.org/10.1177/17474930231181010>Predmety: Male, brain bleed, brain microbleeds, Cerebral hemorrhage, cerebral microbleeds, lipid levels, statin use, Cerebral Hemorrhage / complications, Intracranial Hemorrhages / chemically induced, 610 Medicine & health, Brain bleed, 11459 Center for Molecular Cardiology, Intracranial Hemorrhages / diagnostic imaging, 360 Social problems & social services, Lipid levels, Risk Factors, Atrial Fibrillation, Intracranial Hemorrhages / epidemiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use, Humans, Prospective Studies, Anticoagulants / therapeutic use, Atrial Fibrillation / drug therapy, Aged, Cerebral Hemorrhage, Aged, 80 and over, Research, Stroke / epidemiology, Anticoagulants, 10060 Epidemiology, Biostatistics and Prevention Institute (EBPI), Middle Aged, Magnetic Resonance Imaging, 3. Good health, Atrial Fibrillation / epidemiology, Cerebral Hemorrhage / epidemiology, Stroke, 2728 Neurology (clinical), Brain microbleeds, Cerebral Hemorrhage / diagnostic imaging, Statin use, 2808 Neurology, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke/epidemiology, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Cerebral Hemorrhage/diagnostic imaging, Cerebral Hemorrhage/epidemiology, Cerebral Hemorrhage/complications, Intracranial Hemorrhages/diagnostic imaging, Intracranial Hemorrhages/epidemiology, Intracranial Hemorrhages/chemically induced, Anticoagulants/therapeutic use, Intracranial Hemorrhages, Cerebral microbleeds, Atrial Fibrillation / complications
Popis súboru: application/pdf; moutzouri_et_al_2023_association_of_statin_use_and_lipid_levels_with_cerebral_microbleeds_and_intracranial_hemorrhage.pdf - application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37243540
https://archive-ouverte.unige.ch/unige:179025
https://doi.org/10.1177/17474930231181010
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_86154DFE5D113
https://serval.unil.ch/resource/serval:BIB_86154DFE5D11.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_86154DFE5D11
https://boris.unibe.ch/182976/
https://hdl.handle.net/11380/1368098
https://doi.org/10.1177/17474930231181010 -
12
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: N Engl J Med
The New England Journal of Medicine, 389, 25, pp. 2341-2354
The New England journal of medicine
Hills, T E, Lorenzi, E, Berry, L R, Shyamsundar, M, Al-Beidh, F, Annane, D, Arabi, Y, Aryal, D, Au, C, Beane, A, Bhimani, Z, Bonten, M, Bradbury, C A, Brunkhorst, F M, Burrell, A, Buxton, M, Calfee, C S, Cecconi, M, Cheng, A C, Cove, M E, Detry, M A, Estcourt, L J, Fitzgerald, M, Goligher, E C, Goossens, H, Green, C, Haniffa, R, Harrison, D A, Hashmi, M, Higgins, A M, Huang, D T, Ichihara, N, Jayakumar, D, Kruger, P S, Lamontagne, F, Lampro, L, Lawler, P R, Marshall, J C, Mason, A J, McGlothlin, A, McGuinness, S, McQuilten, Z K, McVerry, B J, Mouncey, P R, Murthy, S, Neal, M D, Nichol, A D, O'Kane, C M, Young, I S, McAuley, D F & REMAP-CAP Investigators 2023, 'Simvastatin in critically ill patients with Covid-19', New England Journal of Medicine, vol. 389, no. 25, pp. 2341-2354. https://doi.org/10.1056/NEJMoa2309995
Bradbury, C A 2023, 'Simvastatin in Critically Ill Patients with COVID-19', New England Journal of Medicine, vol. 389, no. 25, pp. 2341-2354. https://doi.org/10.1056/NEJMoa2309995
REMAP-CAP Investigators, Dark, P & et al. 2023, ' Simvastatin in Critically Ill Patients with Covid-19. ', The New England Journal of Medicine, vol. 389, no. 25, pp. 2341-2354 . https://doi.org/10.1056/nejmoa2309995
The New England Journal of Medicine, vol 389, iss 25
The New England Journal of MedicinePredmety: Radboudumc 4: lnfectious Diseases and Global Health Internal Medicine, Simvastatin, Medical Sciences, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Bioinformatics, Radboudumc 16: Vascular damage Cardiology, Critical Illness, Biomedical Informatics, Medical Specialties, Medicine and Health Sciences, Radboudumc 4: lnfectious Diseases and Global Health Intensive Care, Humans, Clinical Epidemiology, Hospital Mortality, Cardiology - Radboud University Medical Center, 2. Zero hunger, COVID-19/mortality, Intensive Care - Radboud University Medical Center, COVID-19, Bayes Theorem, COVID-19 Drug Treatment, 3. Good health, Critical Illness/mortality, Treatment Outcome, Simvastatin/therapeutic use, Original Article, Public Health, Human medicine, Hydroxymethylglutaryl-CoA Reductase Inhibitors
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37888913
https://research.manchester.ac.uk/en/publications/294c62f6-b6f1-4ee5-84c5-ccf8a90e1bdf
https://doi.org/10.1056/nejmoa2309995
https://hdl.handle.net/20.500.11768/178536
https://doi.org/10.1056/nejmoa2309995
http://hdl.handle.net/10044/1/107848
https://hdl.handle.net/2066/301823
https://repository.ubn.ru.nl//bitstream/handle/2066/301823/301823.pdf
https://hdl.handle.net/10067/2028690151162165141
https://pure.qub.ac.uk/en/publications/5fda3edc-8099-41bf-adc1-6d7b99358b14
https://research-information.bris.ac.uk/en/publications/4692f094-01b0-4f04-9b4d-2a19728a2070
https://hdl.handle.net/1983/4692f094-01b0-4f04-9b4d-2a19728a2070
https://www.mendeley.com/catalogue/884f414b-5322-349b-abfd-09f8f1551a3a/
http://www.scopus.com/inward/record.url?scp=85180969813&partnerID=8YFLogxK
https://research.manchester.ac.uk/en/publications/294c62f6-b6f1-4ee5-84c5-ccf8a90e1bdf
https://doi.org/10.1056/nejmoa2309995
http://europepmc.org/abstract/med/37888913
https://escholarship.org/uc/item/12p0g3j3 -
13
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Acta Cardiologica. 79:58-67
Predmety: Male, Adult, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Anticholesteremic Agents, Anticholesteremic Agents/therapeutic use, Cholesterol, LDL, Middle Aged, 3. Good health, Hyperlipoproteinemia Type II, Young Adult, Belgium, Risk Factors, Hyperlipoproteinemia Type II/diagnosis, young adult, risk factors, Humans, Proprotein Convertase 9, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Belgium/epidemiology, Retrospective Studies
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37882513
https://biblio.vub.ac.be/vubir/a-retrospective-study-of-people-with-familial-hypercholesterolaemia-in-a-belgian-lipid-clinic(830b39b0-2c8a-47c1-a900-077923baa1e6).html -
14
Autori: a ďalší
Zdroj: Bucci, T, Menichelli, D, Palumbo, I M, Pastori, D, Ames, P R J, Lip, G Y H & Pignatelli, P 2025, 'Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications', Cells, vol. 14, no. 5, 353. https://doi.org/10.3390/cells14050353
Predmety: Animals, Anticoagulants/therapeutic use, Antiphospholipid Syndrome/drug therapy, Fibrinolytic Agents/therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Thrombosis/drug therapy, antiphospholipid syndrome, thrombosis, statins, mechanism
Popis súboru: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/40072082; info:eu-repo/semantics/altIdentifier/pissn/2073-4409
Dostupnosť: https://vbn.aau.dk/da/publications/375a3240-4b50-4f92-bf90-59a6ae2a4443
https://doi.org/10.3390/cells14050353
https://vbn.aau.dk/ws/files/777379939/Bucci_et_al._2025_._Statins_as_an_Adjunctive_Antithrombotic_Agent_in_Thrombotic_Antiphospholipid_Syndrome_-_Mechanisms_and_Clinical_Implications.pdf
https://www.scopus.com/pages/publications/105000041392 -
15
Autori: a ďalší
Zdroj: BMJ open, vol. 15, no. 1, pp. e088262
Predmety: Humans, Acute Coronary Syndrome/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Female, Switzerland, Prospective Studies, Exercise, Middle Aged, Aged, Self Report, Cardiovascular Disease, Coronary heart disease, Drug Therapy, Observational Study, PREVENTIVE MEDICINE
Popis súboru: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39819911; info:eu-repo/semantics/altIdentifier/eissn/2044-6055; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_7569DD1484807; https://serval.unil.ch/notice/serval:BIB_7569DD148480; https://serval.unil.ch/resource/serval:BIB_7569DD148480.P001/REF.pdf
-
16
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: J Health Popul Nutr
Journal of Health, Population and Nutrition, Vol 43, Iss 1, Pp 1-12 (2024)Predmety: 11035 Institute of General Practice, RC620-627, Cost-Benefit Analysis, Hypercholesterolemia, 610 Medicine & health, Review, LDL, 03 medical and health sciences, 0302 clinical medicine, Cynara scolymus, Flax, 2307 Health, Toxicology and Mutagenesis, Humans, Nutritional diseases. Deficiency diseases, Garlic, 1106 Food Science, Assessment of Medication Adherence, Biological Products, Statins [Supplementary Concept], Plant Extracts, 2739 Public Health, Environmental and Occupational Health, Dietary supplements, Medicine, Ayurvedic, Treatment Outcome, Red yeast rice, Dietary Supplements, Public aspects of medicine, RA1-1270, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medication Adherence/statistics, Cost-Benefit Analysis [MeSH], Hypercholesterolemia/diet therapy [MeSH], Dietary Supplements/economics [MeSH], Hydroxymethylglutaryl-CoA Reductase Inhibitors/economics [MeSH], Medicine, Ayurvedic [MeSH], Hypercholesterolemia/drug therapy [MeSH], Plant Extracts/economics [MeSH], Biological Products/economics [MeSH], Plant Extracts/therapeutic use [MeSH], Garlic/chemistry [MeSH], Dietary Supplements/adverse effects [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use [MeSH], Hypercholesterolemia/economics [MeSH], Flax [MeSH], Cynara scolymus [MeSH], Biological Products/administration, Biological Products/adverse effects [MeSH]
-
17
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: BMC Cardiovasc Disord
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-11 (2024)Predmety: Male, Adult, Time Factors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Clinical Decision-Making, Practice Patterns, R Medicine (General), Iran, Risk threshold, Risk Assessment, Drug Prescriptions, Decision Support Techniques, Sex Factors, SDG 3 - Good Health and Well-being, Benefit–harm, Diseases of the circulatory (Cardiovascular) system, Humans, Practice Patterns, Physicians', Aged, Physicians', Primary prevention, Research, Age Factors, Statin, Middle Aged, R1, Primary Prevention, Iran/epidemiology, Cardiovascular diseases, Treatment Outcome, Cardiovascular Diseases, Heart Disease Risk Factors, RC666-701, Benefit-harm, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases/prevention & control
Popis súboru: application/pdf
-
18
Autori:
Zdroj: Ugeskrift for Læger. 186(20A)
Predmety: Early Diagnosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hyperlipoproteinemia Type II/diagnosis, Anticholesteremic Agents/therapeutic use, Humans, Child, Cardiovascular Diseases/prevention & control, Denmark/epidemiology
Prístupová URL adresa: https://portal.findresearcher.sdu.dk/da/publications/7016d60d-4ea1-47e4-8618-38491d872f90
-
19
Autori: a ďalší
Zdroj: Circulation. 146(9)
Predmety: Acute Coronary Syndrome: diagnosis, drug therapy, epidemiology, Antibodies, Monoclonal, Humanized, Anticholesteremic Agents: adverse effects, Apolipoproteins B, Atherosclerosis: drug therapy, Cardiovascular Diseases: diagnosis, epidemiology, prevention & control, Cholesterol, Cholesterol, LDL, Heart Disease Risk Factors, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors: therapeutic use, Risk Factors, Treatment Outcome
Popis súboru: application/pdf
-
20
Autori: a ďalší
Zdroj: Clin Res Cardiol
Clinical research in cardiology, 113(6):812-821Predmety: Male, Time Factors, Lipid-lowering therapy, Persistence, Cardiovascular Diseases/drug therapy [MeSH], Medication Adherence/statistics, PCSK9 Inhibitors [MeSH], Aged [MeSH], Germany, Germany/epidemiology [MeSH], Dyslipidemias/blood [MeSH], Male [MeSH], Female [MeSH], Ezetimibe/therapeutic use [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Cardiovascular Diseases/epidemiology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Statins, Time Factors [MeSH], Dyslipidemias/epidemiology [MeSH], Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use [MeSH], Adherence, Anti-PCSK9 antibody, Original Paper, Cholesterol, LDL/blood [MeSH], Dyslipidemias/drug therapy [MeSH], Ezetimibe, Anticholesteremic Agents/therapeutic use [MeSH], Humans, Retrospective Studies, Aged, Dyslipidemias, Assessment of Medication Adherence, Anticholesteremic Agents, PCSK9 Inhibitors, Cholesterol, LDL, Middle Aged, 3. Good health, ddc, Cardiovascular Diseases, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Follow-Up Studies
Popis súboru: application/pdf
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text